Sarepta Therapeutics (SRPT) Change in Intangibles (2017 - 2020)
Sarepta Therapeutics (SRPT) posted quarterly Change in Intangibles of $108.1 million for Q1 2020, down 13.54% quarter-over-quarter from $125.0 million in Q1 2017.
Sarepta Therapeutics (SRPT) Change in Intangibles (2017 - 2020) Analysis & Trends
Sarepta Therapeutics' Change in Intangibles history runs 2 years deep, the most recent figure standing at $108.1 million for Q1 2020.
- In Q1 2020, Change in Intangibles changed N/A year-over-year to $108.1 million; the TTM figure through Dec 2020 stood at $108.1 million (changed N/A YoY), while the FY2023 annual figure was $102.0 million, changed N/A from the prior year.
- Change in Intangibles for Q1 2020 stood at $108.1 million, down from $125.0 million in the prior quarter.
- The five-year high for Change in Intangibles was $125.0 million in Q1 2017, with the low at $108.1 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 108.07 Mn |
| Mar 31, 2020 | 108.07 Mn |
| Mar 31, 2017 | 125.00 Mn |
| Mar 31, 2017 | 125.00 Mn |